太美医疗科技（02576）于2026年10月7日发布翌日披露报表。公告显示，公司于2026年10月7日通过香港联交所场内回购股份共计20,000股，约占前一交易日（2026年10月6日）已发行股本的0.01%。此次回购的最高每股价格为4.90港元，最低每股价格为4.64港元，涉资合计94,990港元，折合约9.50万港元。
根据公告，回购完成后，2026年10月7日公司已发行股本（不含库藏股）数量变动为193,172,533股，库藏股数量增加至7,420,000股，总发行股本仍为200,592,533股。公司此前于2026年6月23日通过购回授权，可回购股数上限为20,017,153股，截至目前已累计回购6,999,000股，占购回授权通过当日已发行股本约3.5%。
公告称，本次股份购回活动已遵守香港联合交易所有限公司的相关上市规则和法例。该公告由公司执行董事及联席公司秘书倪晓梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.